The PharmFilm platform serves as the foundation for Aquestive's most promising product candidate, Anaphylm, an epinephrine sublingual film designed for treating Type 1 allergic reactions ...

The PharmFilm platform serves as the foundation for Aquestive's most promising product candidate, Anaphylm, an epinephrine sublingual film designed for treating Type 1 allergic reactions, including ...

Anaphylm™ (epinephrine) Sublingual Film is a polymer matrix-based epinephrine prodrug product candidate. Anaphylm is similar in size to a postage stamp, weighs less than an ounce, and begins to ...

Anaphylm™ (epinephrine) Sublingual Film is a polymer matrix-based epinephrine prodrug product candidate. Anaphylm is similar in size to a postage stamp, weighs less than an ounce, and begins to ...

prior to its planned NDA submission for Anaphylm™ (epinephrine) Sublingual Film. Anaphylm has the potential to be the first and only orally delivered epinephrine product for the treatment of severe ...

has received positive feedback from the FDA regarding its New Drug Application for Anaphylm™, an innovative sublingual film for treating ... first orally delivered epinephrine treatment, aligns ...

Anaphylm is a portable, easy-to-use sublingual epinephrine for Type 1 allergic reactions. The company also collaborates with pharmaceutical companies to bring new molecules to market using its ...

iX Biopharma is transforming approved drugs such as ketamine into novel therapies using its wafer-based sublingual technology, to develop therapies for pain, depression and more. Since its ...

The firm says this same technology is also being used to develop Anaphylm, and epinephrine sublingual film, for the treatment of Type 1 allergic reactions, including anaphylaxis. Following a ...